|
1
|
Wang YW, Chen HH, Wu MS and Chiu HM;
Taiwanese Nationwide Colorectal Cancer Screening Program, : Current
status and future challenge of population-based organized
colorectal cancer screening: Lesson from the first decade of
Taiwanese program. J Formos Med Assoc. 117:358–364. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gu MJ, Huang QC, Bao CZ, Li YJ, Li XQ, Ye
D, Ye ZH, Chen K and Wang JB: Attributable causes of colorectal
cancer in China. BMC Cancer. 18:382018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brenner DR, Ruan Y, Shaw E, De P, Heitman
SJ and Hilsden RJ: Increasing colorectal cancer incidence trends
among younger adults in Canada. Prev Med. 105:345–349. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhen YH, Liu XH, Yang Y, Li B, Tang JL,
Zeng QX, Hu J, Zeng XN, Zhang L, Wang ZJ, et al: Phase I/II study
of adjuvant immunotherapy with sentinel lymph node T lymphocytes in
patients with colorectal cancer. Cancer Immunol Immunother.
64:1083–1093. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deng Y, Chi P, Lan P, Wang L, Chen W, Cui
L, Chen D, Cao J, Wei H, Peng X, et al: Modified FOLFOX6 with or
without radiation versus fluorouracil and leucovorin with radiation
in neoadjuvant treatment of locally advanced rectal cancer: Initial
results of the Chinese FOWARC multicenter, open-label, randomized
three-arm phase III trial. J Clin Oncol. 34:3300–3307. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Z, He J, Xing X, Li P, Zhang W, Tong
Z, Jing X, Li L, Liu D, Wu Q and Ju H: Mn12Ac inhibits the
migration, invasion and epithelial-mesenchymal transition of lung
cancer cells by downregulating the Wnt/β-catenin and PI3K/AKT
signaling pathways. Oncol Lett. 16:3943–3948. 2018.PubMed/NCBI
|
|
7
|
Mao L, Li Y, Zhao J, Li Q, Yang B, Wang Y,
Zhu Z, Sun H and Zhai Z: Transforming growth factor-β1 contributes
to oxaliplatin resistance in colorectal cancer via epithelial to
mesenchymal transition. Oncol Lett. 14:647–654. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang M, Xu B, Li X, Shang Y, Chu Y, Wang
W, Chen D, Wu N, Hu S, Zhang S, et al: O-GlcNAcylation promotes
colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2
regulatory feedback circuit. Oncogene. 38:301–316. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hashimoto M, Kobayashi T, Tashiro H,
Arihiro K, Kikuchi A and Ohdan H: h-Prune is associated with poor
prognosis and epithelial-mesenchymal transition in patients with
colorectal liver metastases. Int J Cancer. 139:812–823. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang SN, Lee JM, Oh H, Kim U, Ryu B and
Park JH: Troglitazone inhibits the migration and invasion of PC-3
human prostate cancer cells by upregulating E-cadherin and
glutathione peroxidase 3. Oncol Lett. 16:5482–5488. 2018.PubMed/NCBI
|
|
11
|
Zhang T, Wang H and Han L: Expression and
clinical significance of tumor necrosis factor receptor-associated
factor 6 in patients with colon cancer. Iran Red Crescent Med J.
18:e239312016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lou JS, Yan L, Bi CW, Chan GK, Wu QY, Liu
YL, Huang Y, Yao P, Du CY, Dong TT and Tsim KW: Yu Ping Feng San
reverses cisplatin-induced multi-drug resistance in lung cancer
cells via regulating drug transporters and p62/TRAF6 signalling.
Sci Rep. 6:319262016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maeda S, Yoshida H, Ogura K, Mitsuno Y,
Hirata Y, Yamaji Y, Akanuma M, Shiratori Y and Omata M: H. Pylori
activates NF-kappaB through a signaling pathway involving IkappaB
kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric
cancer cells. Gastroenterology. 119:97–108. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kong L, Li X, Wang H, He G and Tang A:
Calycosin inhibits nasopharyngeal carcinoma cells by influencing
EWSAT1 expression to regulate the TRAF6-related pathways. Biomed
Pharmacother. 106:342–348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bilir C, Engin H, Can M, Likhan S,
Demirtas D, Kuzu F and Bayraktaroglu T: Increased serum tumor
necrosis factor receptor-associated factor-6 expression in patients
with non-metastatic triple-negative breast cancer. Oncol Lett.
9:2819–2824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rezaeian AH, Li CF, Wu CY, Zhang X,
Delacerda J, You MJ, Han F, Cai Z, Jeong YS, Jin G, et al: A
hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1α
activation, tumorigenesis and metastasis. Nat Cell Biol. 19:38–51.
2017. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi B, Wang Y and Yin F:
MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT
in nasopharyngeal carcinoma cells. Cancer Biol Ther. 18:792–800.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li SL, Gao HL, Lv XK, Hei YR, Li PZ, Zhang
JX and Lu N: MicroRNA-124 inhibits cell invasion and
epithelial-mesenchymal transition by directly repressing Snail2 in
gastric cancer. Eur Rev Med Pharmacol Sci. 21:3389–3396.
2017.PubMed/NCBI
|
|
19
|
Liu Q, Luo D, Cai S, Li Q and Li X: P-TNM
staging system for colon cancer: Combination of P-stage and AJCC
TNM staging system for improving prognostic prediction and clinical
management. Cancer Manag Res. 10:2303–2314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen S, Chen H, Gao S, Qiu S, Zhou H, Yu M
and Tu J: Differential expression of plasma microRNA-125b in
hepatitis B virus-related liver diseases and diagnostic potential
for hepatitis B virus-induced hepatocellular carcinoma. Hepatol
Res. 47:312–320. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He Z, Yu L, Luo S, Li M, Li J, Li Q, Sun Y
and Wang C: miR-296 inhibits the metastasis and
epithelial-mesenchymal transition of colorectal cancer by targeting
S100A4. BMC Cancer. 17:1402017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu W, Zhang Q, Li S, Li L, Ding Z, Qian
Q, Fan L and Jiang C: The relationship between colonic macrophages
and MicroRNA-128 in the pathogenesis of slow transit constipation.
Dig Dis Sci. 60:2304–2315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li JJ, Luo J, Lu JN, Liang XN, Luo YH, Liu
YR, Yang J, Ding H, Qin GH, Yang LH, et al: Relationship between
TRAF6 and deterioration of HCC: An immunohistochemical and in vitro
study. Cancer Cell Int. 16:762016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hueman MT, Wang H, Yang CQ, Sheng L,
Henson DE, Schwartz AM and Chen D: Creating prognostic systems for
cancer patients: A demonstration using breast cancer. Cancer Med.
7:3611–3621. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L, Dou X, Liu T, Lu W, Ma Y and Yang
Y: Tumor size and lymph node metastasis are prognostic markers of
small cell lung cancer in a Chinese population. Medicine
(Baltimore). 97:e117122018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moody L, He H, Pan YX and Chen H: Methods
and novel technology for microRNA quantification in colorectal
cancer screening. Clin Epigenetics. 9:1192017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pecqueux M, Liebetrau I, Werft W,
Dienemann H, Muley T, Pfannschmidt J, Müssle B, Rahbari N, Schölch
S, Büchler MW, et al: A Comprehensive MicroRNA expression profile
of liver and lung metastases of colorectal cancer with their
corresponding host tissue and its prognostic impact on survival.
Int J Mol Sci. 17(pii): E17552016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J and Ma L: MicroRNA control of
epithelial-mesenchymal transition and metastasis. Cancer Metastasis
Rev. 31:653–662. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fang Y, Gu X, Li Z, Xiang J and Chen Z:
miR-449b inhibits the proliferation of SW1116 colon cancer stem
cells through downregulation of CCND1 and E2F3 expression. Oncol
Rep. 30:399–406. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu X, Duan B, Dong Y, He C, Zhou H, Sheng
H, Gao H and Zhang X: MicroRNA-139-3p indicates a poor prognosis of
colon cancer. Int J Clin Exp Pathol. 7:8046–8052. 2014.PubMed/NCBI
|
|
32
|
Zhang J, Lu Y, Yue X, Li H, Luo X, Wang Y,
Wang K and Wan J: MiR-124 suppresses growth of human colorectal
cancer by inhibiting STAT3. PLoS One. 8:e703002013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang MJ, Li Y, Wang R, Wang C, Yu YY, Yang
L, Zhang Y, Zhou B, Zhou ZG and Sun XF: Downregulation of
microRNA-124 is an independent prognostic factor in patients with
colorectal cancer. Int J Colorectal Dis. 28:183–189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qiu Z, Guo W, Wang Q, Chen Z, Huang S,
Zhao F, Yao M, Zhao Y and He X: MicroRNA-124 reduces the pentose
phosphate pathway and proliferation by targeting PRPS1 and RPIA
mRNAs in human colorectal cancer cells. Gastroenterology.
149:1587–1598.e11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ueno H, Hase K, Hashiguchi Y, Shimazaki H,
Yoshii S, Kudo SE, Tanaka M, Akagi Y, Suto T, Nagata S, et al:
Novel risk factors for lymph node metastasis in early invasive
colorectal cancer: A multi-institution pathology review. J
Gastroenterol. 49:1314–1323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han L, Jiang Y, Han D and Tan W: Hsp27
regulates epithelial mesenchymal transition, metastasis and
proliferation in colorectal carcinoma. Oncol Lett. 16:5309–5316.
2018.PubMed/NCBI
|
|
37
|
Guo Q, Zhao Y, Chen J, Hu J, Wang S, Zhang
D and Sun Y: BRAF-activated long non-coding RNA contributes to
colorectal cancer migration by inducing epithelial-mesenchymal
transition. Oncol Lett. 8:869–875. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang WL, Wang J, Chan CH, Lee SW, Campos
AD, Lamothe B, Hur L, Grabiner BC, Lin X, Darnay BG and Lin HK: The
E3 ligase TRAF6 regulates Akt ubiquitination and activation.
Science. 325:1134–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang X, Wu L, Xiao T, Tang L, Jia X, Guo
Y, Zhang J, Li J, He Y, Su J, et al: TRAF6 regulates EGF-induced
cell transformation and cSCC malignant phenotype through
CD147/EGFR. Oncogenesis. 7:172018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Han F, Zhang L, Qiu W and Yi X: TRAF6
promotes the invasion and metastasis and predicts a poor prognosis
in gastric cancer. Pathol Res Pract. 212:31–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun H, Li X, Fan L, Wu G, Li M and Fang J:
TRAF6 is upregulated in colon cancer and promotes proliferation of
colon cancer cells. Int J Biochem Cell Biol. 53:195–201. 2014.
View Article : Google Scholar : PubMed/NCBI
|
